Johnson & Johnson



US: Johnson & Johnson ordered to pay $8bn over male breast growth

Multinational company Johnson & Johnson has been ordered to pay $8 billion in punitive damages to a man who said the firm had not issued a warning that its antipsychotic drug could lead to breast growth.

Published 9 October 2019